Academic Detailing Bill Could Be Interim Step To Comparative Effectiveness

Congressional critics of pharmaceutical marketing practices launched another volley in their battle to curb industry influence on prescribers with the July 31 introduction of legislation that would create a federally-supported "academic detailing" program